EUVIMEDAvasta EUVIMED
Open access · CC BY-NC 4.0

Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition

Lijing Du, Shikai Yan, Xiaopeng Ren, Syed Shams Ul Hassan, Yuanfang Sun, Yu Gan, Xue Xiao iD, Shasha Li iD, Huizi Jin iD

Phytotherapy Research · 2026-11 · 40 (11) · 6216-6232

DOI: 10.1002/ptr.70432 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-08-24. Written by Lijing Du and 8 co-authors. Institution: Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China. Major MEDLINE topics: Alzheimer Disease, Plant Oils, Sapindaceae. 56 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Natural Science Foundation of China, National Key R&D Program of China, Joint Funds of National Natural Science Foundation of China.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with cognitive decline and neuroinflammation. Xanthoceras sorbifolia Bunge oil (XSBO), a woody plant oil rich in bioactive fatty acids, has shown potential health benefits. This study aimed to investigate the neuroprotective effects and underlying mechanisms of XSBO in AD. A scopolamine‐induced AD rat model was established to evaluate the effects of XSBO on cognitive function, pathological changes, and neuroinflammation. Gut microbiota alterations were analyzed by 16S rDNA sequencing. Fecal microbiota transplantation (FMT) and short‐chain fatty acid (SCFA) supplementation experiments were performed to explore the role of gut microbiota‐derived metabolites. The TLR4/MyD88/MAPK signaling pathway was further examined. XSBO treatment improved cognitive deficits, reduced neuronal damage and neuroinflammation, and enhanced intestinal barrier integrity in AD rats. XSBO restored gut microbiota dysbiosis and increased SCFA‐producing bacteria. FMT and SCFA supplementation confirmed that microbiota‐derived metabolites contributed to XSBO‐mediated cognitive improvement and neuroprotection. Mechanistically, XSBO inhibited lipopolysaccharide‐induced neuroinflammation by suppressing TLR4/MyD88/MAPK signaling activation. XSBO alleviates AD‐related cognitive impairment and neuroinflammation by modulating the gut microbiota–SCFA axis and inhibiting TLR4/MyD88/MAPK‐mediated inflammatory responses. These findings suggest that XSBO may serve as a promising dietary intervention for neurodegenerative disease management.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseasePlant OilsSapindaceaeAnimalsToll-Like Receptor 4Gastrointestinal MicrobiomeRatsMyeloid Differentiation Factor 88MaleBrainNeuroprotective AgentsRats, Sprague-DawleyMAP Kinase Signaling SystemDisease Models, AnimalSignal Transduction

Author keywords

Xanthoceras sorbifolia Bunge oilAlzheimer's diseaseTLR4/Myd88/MAPK pathwayintestinal microbiotaneuroinflammatoryshort‐chain fatty acids

Substances

Toll-Like Receptor 4Myeloid Differentiation Factor 88Plant OilsTlr4 protein, ratNeuroprotective AgentsMyd88 protein, rat

Authors and institutions

  • Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
  • The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Institute of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
  • School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Jiyuan Neurohealth Industry Research Institute of Guangdong Pharmaceutical University, Jiyuan, Henan, China.

ORCID profiles: Xue Xiao, Shasha Li, Huizi Jin

Funding

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Joint Funds of National Natural Science Foundation of China
  • National Key Research and Development Program of China

Cite

APA

Du, L., Yan, S., Ren, X., Hassan, S. S. U., Sun, Y., Gan, Y., Xiao, X., Li, S., & Jin, H. (2026). Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition. Phytotherapy Research, 40(11), 6216-6232. https://doi.org/10.1002/ptr.70432

Vancouver

Du L, Yan S, Ren X, Hassan SSU, Sun Y, Gan Y, et al. Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition. Phytotherapy Research. 2026;40(11):6216-6232. doi:10.1002/ptr.70432

BibTeX
@article{Du2026,
  author = {Du, Lijing and Yan, Shikai and Ren, Xiaopeng and Hassan, Syed Shams Ul and Sun, Yuanfang and Gan, Yu and Xiao, Xue and Li, Shasha and Jin, Huizi},
  title = {Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6216--6232},
  doi = {10.1002/ptr.70432}
}
Start for free →